Gregory R. Friberg

CIK: 0002038768

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (20.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (30.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BMRN

BIOMARIN PHARMACEUTICAL INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

BMRN
BIOMARIN PHARMACEUTICAL INC
Sep 30, 2026
Tax Payment(F)
Direct
4.1K shares at avg. $60.00$245K
BMRN
BIOMARIN PHARMACEUTICAL INC
May 7, 2026
Sale(S)
Direct
3.3K shares at avg. $53.85$177K
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 17, 2026
Tax Payment(F)
Direct
1.6K shares at avg. $56.05$91K
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 16, 2026
Award(A)
Direct
19.2K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Feb 26, 2026
Sale(S)
Direct
6.3K shares at avg. $60.38$382K
BMRN
BIOMARIN PHARMACEUTICAL INC
Oct 31, 2025
Award(A)
Direct
398 shares at avg. $45.53$18K
BMRN
BIOMARIN PHARMACEUTICAL INC
Sep 30, 2025
Tax Payment(F)
Direct
3.3K shares at avg. $54.16$179K
BMRN
BIOMARIN PHARMACEUTICAL INC
Mar 17, 2025
Award(A)
Direct
17.8K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Sep 30, 2024
Award(A)
Direct
7.9K shares-
BMRN
BIOMARIN PHARMACEUTICAL INC
Sep 30, 2024
Award(A)
Direct
21.2K shares-

		Type	Shares	Price		Ownership
Sep 30, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	4,086	$60.00	$245,160	Direct
May 7, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Sale(S)	3,281	$53.85	$176,682	Direct
Mar 17, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	1,629	$56.05	$91,305	Direct
Mar 16, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	19,150	-	$0	Direct
Feb 26, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Sale(S)	6,326	$60.38	$381,937	Direct
Oct 31, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	398	$45.53	$18,123	Direct
Sep 30, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Tax Payment(F)	3,304	$54.16	$178,945	Direct
Mar 17, 2025	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	17,750	-	-	Direct
Sep 30, 2024	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	7,870	-	$0	Direct
Sep 30, 2024	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	21,190	-	$0	Direct

1-10 of 10 transactions

About Friberg Gregory R

Friberg Gregory R (SEC CIK 0002038768) files insider reports with the SEC as EVP, Chief R&D Officer of BIOMARIN PHARMACEUTICAL INC (BMRN).

Signal8 holds 9 ownership filings by Friberg Gregory R (1 Form 3, 7 Form 4, 1 Form 5), filed between Oct 1, 2024 and Oct 1, 2026. Those filings report 10 transactions, from Sep 30, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Friberg Gregory R's filings is in SAN RAFAEL, CA.

Recent filings by Friberg Gregory R

Sep 30, 2026: Tax withholding of BMRN shares (Form 4, code F).
May 7, 2026: Open-market sale of BMRN shares (Form 4, code S).
Mar 17, 2026: Tax withholding of BMRN shares (Form 4, code F).
Mar 16, 2026: Grant or award of BMRN shares (Form 4, code A).
Feb 26, 2026: Open-market sale of BMRN shares (Form 4, code S).

Other insiders filing for BIOMARIN PHARMACEUTICAL INC (BMRN)

Plenge Robert M, Director
Davis George Eric, EVP, Chief Legal Officer
Countouriotis Athena, Director
Walbert Timothy P, Director
Ho Maykin, Director
HOMBACH ROBERT J., Director

How to read Form 4 transaction codes